Stock GNPX GENPREX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Genprex, Inc.

Equities

GNPX

US3724462037

Market Closed - Nasdaq
Other stock markets
 21:00:00 31/05/2024 BST 		5-day change 1st Jan Change
3.11 USD +28.51% Intraday chart for Genprex, Inc. +41.36% -66.20%
05-15 Genprex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-14 Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa Immunogene Therapy in Combination with Tecentriq to Treat Small Cell Lung Cancer CI
a61096494f2e9dfdbc47eb4a2eaab8e6._15jq2NpqJxuSdWDRprIfYhmOCFRPvkA2xnn7vOhQiA.iw837QId2Ng5HePIIf77UNAreWwUVclmv3bQn4ruOG-bOlbGFl_m1zY9nA~064c96228d78178fe6a9351f034a504d
  1. Stock Market
  2. Equities
  3. GNPX Stock
  4. Charts Genprex, Inc.
  5. News Chart